ABSTRACT SUBMISSIONS FOR ISSPP 2022 NOW CLOSED

SUBMIT YOUR SCIENTIFIC RESEARCH TO ISSPP 2022

As you prepare your submission to the Meeting, please make sure to review the Abstract Reference Guidelines below and make note of the following details:

• Abstracts may ONLY be submitted online.
• There are no restrictions on the number of abstracts you may submit.
• Abstract presented at other national meetings or previously published should not be submitted to ISSPP 2022.
• Science only!
  • Abstracts may NOT be about products or lines of business.
• No submission extensions will be granted.

AUTHOR & SUBMISSION ELIGIBILITY

As you prepare your submission to the Meeting, please make note of the following eligibility criteria:

• ISSPP will not accept abstract submissions from authors and/or co-authors who are employees of pharmaceutical, biotechnology, or medical technology companies.
• There is a limit of 50 co-authors for each abstract.
• Authors of all accepted abstracts are expected to register for ISSPP 2022 and pay the meeting registration fee. 
• It is ISSPP’s intent to have a live in-person meeting to present your work. It is strongly encouraged that the accepted oral abstract presenters will need to be present in-person in Huntington Beach. In the event of a travel ban, ISSPP will explore options for virtual presentation.
• Posters will be in an electronic format with current plans for an in-person meeting, COVID permitting.

ABSTRACT SELECTION PROCESS & PRESENTATIONS

All abstracts are subject to a blind peer-review by members of the ISSPP Scientific Program Committee. The Scientific Program Committee and ACT Program Committee make all final decisions relative to the abstract selection and scheduling.

All reviewers, session planners and invited faculty will be required to disclose all financial relationships through the online system, helping to ensure high-quality, unbiased presentations and compliance with CME regulations. In addition, all authors must disclose all financial relationships during the submission process before their abstract will be considered and graded.

CALL FOR ABSTRACTS REFERENCE GUIDE

This year, the 3^rd Annual ISSP Congress will take place October 13-14, 2022, in Huntington Beach, California at the Paséa Hotel. The ISSPP Scientific Program Committee invite you to submit your abstracts via Call for Abstracts. The Committee encourages anyone involved in the management and investigation of pleural or peritoneal surface malignancies to submit their scientific work and make this the best meeting yet.

ABSTRACT SUBMISSION CLOSED ON AUGUST 15, 2022, AT 11:59 PM (GMT)
 

ABSTRACT SUBMISSION REQUIREMENTS

As you prepare your abstract submission to the meeting, please make note of the following requirements and instructions.

Character Limit: There is a limit of 2,300 characters for the text of your abstract submission. This includes the title and abstract body, including all spaces. If you copy and paste the title and/or body from your word processor, most special characters will transfer. You can replace special characters and/or insert formatting tags using the character palette.

Title: The title should be entered in mixed case (upper and lower-case letters). DO NOT enter the title in all capital or all lower-case letters. Do not use formatting tags. The title will be formatted automatically by the system at the time of print production. Abbreviations must not be used in the title. Use generic product names in the title. Titles with product/brand names will disqualify the abstract.

Abstract Body: Include the following:

INTRODUCTION: The introduction should be 2 or 3 brief sentences describing the objectives of the study.

METHODS: A description of the methods used to conduct the study must be included (i.e., retrospective chart review, prospective trial). Detailed descriptions of laboratory techniques should not be included. Do not mention the institution where the work was performed in the body or title of the abstract.

RESULTS: The results should occupy one-half to two-thirds of the abstract, and specific data necessary to evaluate the abstract should be included. If there is concern that additional data would enhance the abstract, then please strongly consider including it. Statements such as "data will be discussed at the presentation" are grounds for disqualification.

CONCLUSIONS: The conclusion should be no more than 2 or 3 sentences regarding the significance of the results in the context of the original objectives.

Questions to address in the abstract:

1. Why was the study conducted?

2. How was the study conducted?

3. What were the results of the study?

4. What is the importance of the results?

Learning Objective: Your learning objective should be a clear, concise statement of what participants should be able to do as a result of the CME activity.

Table or Image: You may add one table OR one image to your Oral or ePoster abstract (not both). Characters will not be deducted from the total character count for tables and images. Tables and Images can be easily edited or deleted any time before the submission deadline.

Presentation Type: You may select one of the following options when submitting your abstract:

Accept for Either Oral or Poster; Oral Presentation Only; Poster Session Only

Disclosures: All authors and presenters must disclose any conflicts of interest and acknowledge any support from commercial interests for studies relating to the abstract. All authors and coauthors must agree with the abstract content to be considered for presentation.

CONFLICT OF INTEREST POLICY As required by the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, all educational planners, presenters, instructors, moderators, authors, reviewers and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with an ineligible company (the ACCME defines an “ineligible company” as any entity producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients) that have occurred within the past 24 months. The ACCME considers financial relationships to create conflicts of interest when individuals have both a financial relationship with an ineligible company and the opportunity to affect the content of CME about the products or services of that ineligible company. All identified conflicts of interest must be resolved, and the educational content vetted for fair balance, scientific objectivity and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off label; experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. ACCME does not consider providers of clinical service directly to patients to be ineligible companies.

CONTESTS & AWARDS

ISSPP is offering two awards for top abstracts submitted for ISSPP Congress 2022. Highest ranking abstracts from Young Investigators (within 10 years from the terminal doctoral degree or fellowship training). To be considered for the award, please submit a letter of verification from your division or department head and indicate that you are applying for the Young Investigators Award.  

Awardees will receive a 2-night stay at the ISSPP Congress venue, and the registration fee will be waived. 

Please Note: Awardees will be required to present their work in person at the Third Annual ISSPP Congress 2022, and attend the award ceremony. 

ABSTRACT SELECTION PROCESS & PRESENTATIONS

All abstracts are subject to a blind peer-review by members of the ISSPP Scientific Program Committee. The Committee makes all final decisions relative to the abstract selection and scheduling. All reviewers, session planners and invited faculty will be required to disclose all financial relationships through the online system, helping to ensure high-quality, unbiased presentations and compliance with CME regulations. In addition, all authors must disclose all financial relationships during the submission process before their abstract will be considered and graded.

Common Reasons Abstracts are Refused:

• No Learning Objective identified
• Incomplete disclosure information
• Paper presented or published elsewhere
• Previously reported study
• Too little data
• Inadequate controls
• Methods of study not indicated
• Insignificant study
• Abstract did not conform to guidelines
• Author or Institution mentioned in body or title
• Conclusion is questionable in relationship to data presented
• Authors are employees of pharmaceutical, biotech or medical technology companies

ABSTRACT NOTIFICATIONS

Each abstract submitter will receive an email acknowledging receipt of the abstract after initiating a submission and after completing a submission. If the abstract is selected for inclusion in ISSPP Congress 2022, the presenting author listed will receive an invitation to participate from the Scientific Program Committee by late-August 2022. If the abstract is not selected, the submitting author will receive a communication regarding its decision by late-August 2022. If a first author/presenter chooses to withdraw his or her abstract for any reason, a request must be submitted by September 15, 2022. Any abstract withdrawal requests received after this date will be considered on a case-by-case basis and cannot be assured removal from the meeting materials.

WHERE & HOW TO SUBMIT YOUR ABSTRACT

1 - Abstracts should be submitted at https://mc.manuscriptcentral.com/pap

2 - Abstract submitters should mention in their cover letter that they are submitting their abstract for the Third Annual ISSPP Congress 2022.

3 – Abstract submitters should select the manuscript designation type as '"congress abstract"

4 – Each abstract submission will be charged with 15 €